study, experiments were performed using mouse spleen cells modified with lower concentrations oftrinitrobenzene sulfonate (TNBS) than commonly used to determine whether strain-dependent differences in CML responses could be detected, and if so, whether they would be linked to the H-2 complex. This report compares the CML responses of spleen cells from various mouse strains to syngeneic cells modified with low concentrations of TNBS, and discusses the potential relevance of Ir-gene effects and self recognition at low immunogen doses.
Materials and Methods
Mice. All mice used were males, 7-12 wks old. The C3H/HeJ, C3H.SW, and all the C57BL/10 congenic mouse strains were purchased from The Jackson Laboratory, Bar Harbor, Maine. The BALB.K and BALB.B strains were kindly provided by Dr. D. H. Sachs, Immunology Branch, National Cancer Institute. The BALB/c and B 10.A (5R) strains were obtained from the Animal Production Unit, National Cancer Institute.
Cell Cultures. Mouse spleen cells (7 × 10 n) were cultured with 3 × 106 irradiated (2,000 rads) TNBS-modified autologous spleen cells for 5 d as previously described (4, 22) . Modification of stimulating, blocking, and target cells was performed by incubation of cells at 37°C for 10 min, as described (4, 22) , with various concentrations of TNBS (0.05-10.0 mM) diluted in phosphate-buffered saline.
Preparation of TNP-conjugated bovine serum albumin and bovine gamma globulin, and the stimulation of spleen cell cultures with these TNP-conjugated proteins have been described in an earlier report (22) .
The 4-h 51Cr-release assays and the nonradiolabeled cold target blocking assays were performed as reported elsewhere (4, 22) . The target cells used were mouse spleen cells, stimulated 48 h before assay with 1 #g/ml phytohemagglutinin PHA, except where otherwise indicated. The blocking cells used were freshly harvested mouse spleen cells.
The percent iysis is calculated as previously described (22) and standard errors of the mean have been excluded from the table and the figures for simplicity, because they were usually <5%.
Immunofluorescence and Flow Microfluorometry. Fluoresceinated anti-TNP antibodies were prepared, B10.BR and C57BL/10 (B10) spleen cells were stained and fixed, and flow microfluorometry was performed as described in a previous report (23) using a FACS II flow microfluorometer (Becton, Dickinson Electronics Laboratory, Mountain View, Calif.).
Results

Strain-dependent Differences of Cytotoxic Responses to Autologous Cells Modified with Low Concentrations of TNBS. Spleen cells from B10.BR (H-2 k) and B10 (H-2 b) mice were
compared for their ability to generate cytotoxic responses to TNP-selfwhen stimulated in vitro with autologous spleen cells modified with different concentrations of TNBS (e.g., 10, 0.3, and 0.1 mM). The results of a representative experiment are summarized graphically in Fig. 1 . Strong cytotoxic activity was observed by B10.BR effectors, irrespective of the TNBS concentration used for modification. At the effector:target cell ratios shown, no differences were detected in lytic activity of B10.BR effectors generated with 10, 0.3, or 0.1 mM TNBS modification. This is partly a result of the fact that the effector cell titration curve is still on the plateau for B 10.BR in this range (see other figures). In contrast to the B10.BR results, lytic activity of B10 spleen cells was detected in cultures stimulated with TNP-self at 10 mM TNBS, but not at 0.3 or 0.1 mM TNBS. Furthermore, although comparable lysis was observed at an effector: target cell ratio of 40:1 for B 10.BR and B 10 effectors stimulated with 10 mM TNBS, B10 effector cell activity titered out more rapidly than that of the B10.BR effectors. At least fourfold more B10 than B10.BR effectors were required to obtain 50% lysis. These results indicate that H-2-1inked strain-dependent differences exist between the B10.BR and BI0 effectors to TNP-self.
To make a more thorough comparison of the cytotoxic responses of B10.BR and B 10 spleen cells to TNP-self modified with different TNBS concentrations, B 10.BRand B10-stimulating spleen cells were modified with twofold dilutions of TNBS ranging from 2.0 to 0.031 mM, and added to cultures of B 10.BR-and B 10-responding cells, respectively. The lytic activity of the effectors generated was assayed on B 10.BR-TNBS and B10-TNBS targets modified with I0 mM TNBS, and is summarized in Fig. 2 . B10.BR effector cell activity was strong and about equal by stimulation in the range between 2.0 and 0.25 mM TNBS. A slight decrease was noted at 0.12 and 0.062 mM, and still lower activity was detected at 0.031 mM, although stimulators treated with all concentrations of TNBS were immunogenic. In contrast, B10 effector cell activity was much more dependent on the TNBS concentration used for stimulating cell modification. Modification with 1.0 mM TNBS generated effector activity approximately equivalent to that observed with B 10.BR spleen cells stimulated with 0.031 mM TNBS. For comparison, the effectors generated were also assayed on the respective TNBS-modified H-2 nonmatched targets. The results summarized in Fig.  2 C and 2 D illustrate that the B 10.BR effectors lysed B 10-TNBS targets better than B10 effectors lysed B10.BR-TNBS targets, and that the stimulatory differences detected in these two strains on their respective modified H-2 matched targets are also reflected on modified H-2 unmatched target cells.
Strain Differences Are Independent of the Degree of TNP Conjugation of Individual Stimulating
Cells. The possibility exists that the differences observed in the CTL responses of B10.BR and B10 spleen cells could have resulted from the conjugation of different amounts of TNP to the cell-surface proteins of B10.BR and B10 spleen cells. To test this possibility, B 10.BR and B 10 spleen cells were modified with different concentrations of TNBS, and then incubated with affinity-purified sheep anti-TNP IgG antibodies conjugated with fluoreseein isothiocyanate (23) . The modified and stained cells were compared for their relative anti-TNP fluorescence intensity by flow microfluorometry using the FACS II flow microfluorometer (23) . As summarized in Table  I , the mean fluorescence data obtained from the FACS II profiles indicate that quantitatively equivalent amounts of anti-TNP antibody were bound to the modified cells of the two strains for any given concentration of TNBS, which is consistent with equal numbers of TNP groups conjugated to the cell surfaces of BI0.BR and BI0 spleen cells. Therefore, the differences observed between the cytotoxic responses of B10.BR and B10 spleen cells to TNP-self using low concentrations of TNBS do not appear to be a result of different amounts of TNP on the stimulating cells of these two strains, and can be attributed to some immunogenetic parameter(s).
Strain Differences to Low Doses of TNP by Stimulation with TNP-Conjugated Proteins or Low Dose TNBS-modified Glass-Adherent Cells.
It has been previously shown that TNPspecific, H-2-restricted effector cells can be generated by stimulating cultures of mouse spleen cells with TNP-eonjugated proteins (22) . Such stimulation might introduce limiting amounts of TNP in an immunogenic form on the cell surface, which could result in activation of B10.BR but not B10 effector cell clones. Cultures of B10.BR and B10 spleen cells were stimulated with 100 #g/ml of: (a) TNP-conjugated bovine gamma globulin (TNP-BGG); (b) BGG; (c) TNP-conjugated bovine serum albumin (TNP-BSA); or (d) BGG. B10.BR and B10 effector cell activity was assessed 5 d later on 10 mM TNBS-modified H-2 k (RDM-4) and H-2 b (EL-4) tumor targets, respectively. The results, illustrated in Fig. 3 , indicate that B10.BR spleen cells generated cytotoxic activity when stimulated with 10 mM TNBS-modified syngeneic cells or with either TNP-BGG or TNP-BSA. In contrast, B10 spleen cells did not generate eytotoxic activity above control values when stimulated with TNP-BGG or TNP-BSA, although these spleen cells did generate a strong response when stimulated with syngeneic cells modified with 10 mM TNBS. The absence of reactivity in the B10 strain to 100 #g/ml of TNP-BGG or TNP-BSA parallels the observation that the amount of TNP bound to the cell surface corresponds to a TNP modification of from 0.1 to 1.0 mM TNBS (22) .
Glass-adherent spleen cells modified with 10 mM TNBS have been shown to be ~10 times more efficient on a per cell basis in stimulating the generation of TNP- 
Demonstration of Strain Differences in Target Cells Modified with Low Concentrations of TNBS.
The results presented above indicate that differences between the CTL responses of B10.BR and B10 cells to low doses of TNP-self can be demonstrated during sensitization, i.e., at the responder and/or stimulator cell level. To determine whether such TNP dose-dependent differences can also be detected between these two strains at the lytic phase, B10.BR and B10 spleen cells were sensitized to TNPself modified with 10, 1.0, or 0.1 mM TNBS. The effectors generated were assayed 5 d later on syngeneic PHA-stimulated blast targets modified with 10, 1, or 0.1 mM TNBS at an effector:target cell ratio of 40:1 to detect maximum lysis. The results, shown in Table II , indicate that B 10.BR effector-cell activity was generated to TNPself at 10, 1, or 0.1 mM TNBS, and that the lytic activity could be detected on TNPself targets modified with 10, 1, 0.1 mM TNBS. In contrast, B 10-effector cell activity was generated to TNP-self only at 10 mM. This lyric activity was detected on TNPself targets modified with 10 and 1 mM TNBS, but not on TNP-self modified with 0.1 mM TNBS. These results suggest that modification of B10 spleen cells with 0.1 mM TNBS fails to form the necessary target antigen(s) or antigenic complex required for lysis by B 10 effectors. The above finding is confirmed and extended by the results of a similar experiment summarized in Fig. 6 , which is assayed on TNP-self and TNP-allogeneic (for crossreactive lysis) targets at several effector:target cell ratios. B10.BR effectors generated by sensitization to TNP-self at 10, 1, or 0.1 mM TNBS lysed TNP-selftargets modified with 10, 1, or 0.1 mM TNBS. B10 effectors generated by sensitization to TNP-self at 10 or 1 mM TNBS lysed TNP-self targets modified with 10 or 1 mM TNBS, but not those modified with 0.1 mM TNBS. Furthermore, no B 10 effector activity could be detected by sensitization with 0.1 mM TNBS and assaying on TNP-self targets modified with 10 or 1 mM TNBS. With respect to cross-reactive lysis, little or no lysis was detected on modified B10.BR targets by B 10 effectors except when both the B 10 stimulators and the B10.BR targets were modified with 10 mM TNBS. B10 targets modified with 10 or 1 raM, but not 0.1 mM TNBS, were weakly lysed by BR effectors generated by sensitization of TNP-self treated with 10 or 1 mM but not with 0.1 mM TNBS. These results indicate that B10 spleen cells do not generate effectors when ./jJ 1xl- stimulated with low doses of TNP-self which lyse B10.BR targets modified with low concentrations of TNBS, and that B 10.BR effectors generated with low doses of TNPself do not lyse B10 targets modified with low concentrations of TNBS, despite the fact that the low-dose B10.BR effectors and targets are adequate for detecting cytotoxic activity on modified self targets.
The Strain Differences in Cytotoxic Response to Syngeneic Cells Modified with Low Concentrations of TNBS Are H-2 Linked.
The observation that the congenic resistant B 10.BR and B 10 strains which share the B 10 background and differ only at H-2 were the respective responder and nonresponder to low concentrations of TNP was consistent with the differences being controlled by genes which are linked to the H-2 complex. To verify this, the cytotoxic responses to TNP-self by other congenic H-2 k and H-2 b strains on the C3H and BALB genetic backgrounds were compared. Irrespective of the non-H-2 background, spleen cells from H-2 k mice responded well to syngeneic cells modified with 10 or 0.1 mM TNBS (Fig. 7) . In contrast, cells from H-2 b mice responded moderately to syngeneic cells modified with 10 mM, but not to those modified with 0.1 mM TNBS.
To provide more information on the cytotoxic responses of other B10 congenic strains to low concentrations of TNP-self, spleen cells from B10.A and B 10.D2 mice were compared with those from B10.BR to syngeneic cells modified with 10, 1.0, or 0.1 mM TNBS (Fig. 8) . B 10.A spleen cells generated strong cytotoxic activity when stimulated with syngeneic cells modified with any of the three concentrations of TNBS (similar to B 10.BR). B 10.D2 spleen cells generated moderate to strong responses to syngeneic cells modified with 10 or 1.0 mM TNBS, but only marginal responses to cells modified with 0.1 mM TNBS (similar to B10). Thus,//-2 k and/-/-2 ~ but not H-,4' and H-2 a strains appear to generate strong cytotoxic activity to low concentrations of TNP-self. 
The H-2 Associated Differences in Cytotoxic Response to Syngeneic Cells Modified with Low Concentrations of TNBS Are Expressed by (BIO × BIO.BR)F1 Responding and Stimulating
Discussion
The present study demonstrates the existence of H-2-1inked genetic differences in the ability of mouse spleen cells to generate cytotoxic effector cell activity specific for TNP-self targets, by limiting the amount of TNBS used to modify the stimulating or target cells or by using limiting numbers of TNP-self stimulator cells. H-2 a and H-2 k strains are high responders to TNP-self, whereas H-2 b and H-2 a strains are low responders; (H-~' × H-2k)F1 mice are high responders to H-2k-TNP but lower responders to H-2b-TNP. The observed genetic differences in responses to TNP-self could result from a relative defect in the low responder strains during the sensitization Effector cell activity was assayed at effector:target PHA-stimulated syngeneic spleen blasts.
cell ratio of 40:1 on 48-h 1415 phase (involving the responder, stimulator, helper, or presenting cells) or during the lytic phase of the response (involving the effector or target cells). Defects expressed at the stimulator and/or target cell levels could conceivably be a result of the failure of cells from low responder mice modified with limiting doses of TNBS to form immunogenic self-TNP complexes. Such would be the case if low doses of TNP specifically failed to modify the relevant low responder haplotype H-2 structures required for self recognition either because low responder cells were generally less susceptible to modification by TNP or because low responder cells expressed fewer self-recognition determinants than high responder cells. Alternatively, the defect might result from an inability of low responder cells to respond to competently presented TNP-modified self antigens. This might result from decreased affinity or decreased frequency of self-TNP specific cytotoxic precursor cells in low responder strains, or could result from a generally lower cytotoxic activity of low responder effector clones. The microfluorometry data shown in Table I indicate that the observed genetic differences are not a result of detectable differences in the total amount of TNP conjugated to the surfaces of B10 and B10.BR spleen cells at any given TNBS concentration. Furthermore, the fact that these strain-dependent differences could be observed by varying the total amount of TNP in the culture, either by sensitizing the responding cells by using a constant number of stimulator cells modified with varying concentrations of TNBS or by using a constant relatively high concentration of TNBS (10 raM) for modification and varying the stimulator cell number, indicates that the density of TNP group per cells in the range studied was not the only important factor. A 10-fold decrease in the TNBS concentration used for modifying the stimulating cells resulted in a more drastic reduction in the level of CTL generated than a 10-fold dilution in the number of stimulating cells (modified with 10 mM TNBS). However, this result does not exclude the possibility that fewer relevant determinants are modified on H-2 b than on H-2 k cells. Nevertheless, the finding that the strain- dependent differences can be detected by using a lower number of stimulating cells modified with a fixed concentration of TNBS is consistent with the density of TNP molecules on the cell surface being less limiting than some other determinant in the low responder haplotype. It is not known whether there are quantitative differences in the amount of H-2 molecules relevant for recognition by CTL per cell on H-2 b and H-2 k spleen cells. If no overall difference exists, it is still possible that self recognition structures relevant for TNP recognition constitute a minor component of the total K and D antigens. These components could differ significantly in H-2 b and H-2 k mice. It should be noted that Forman and eoworkers (25) (26) (27) (28) have made an extensive study of the amount of TNP conjugated to cell-surface proteins as a function of TNBS concentrations. Their investigations indicated that a direct correlation could be demonstrated between the ability of modified syngeneic murine cells to serve as stimulators or targets in the H-2-restricted TNP-specific CML and the degree of conjugation of TNP groups to H-2 antigens (26). 
D).
Our results indicate that a defect in H-2 b spleen cells can be detected by lowering the TNBS concentration used to modify the target cells.//-2 ~ but not H-2 ~ effector cells activated by 10 mM TNP-self lysed 0.1 mM TNBS-modified syngeneic target cells, which demonstrates a target cell defect, or an inability of H-2 b lymphocytes to react with syngeneic stimulator or target cells modified with 0.1 mM TNBS. The results obtained with cross-reactive lysis on TNBS-modified H-2-nonmatched targets are also compatible with a defect at the target cell level which could be independent of effector cell generation, because B 10.BR effectors lysed B 10.BR but not B 10 targets modified with low concentrations of TNBS. However, the TNP cross-reactive data also suggest that a defect probably exists at the responding and/or stimulating cell level, because B 10 effectors generated by stimulation with low doses of TNP-self did not lyse B 10.BR targets modified with 10 mM TNBS, although the same targets were lysed by BR effectors generated with low doses of TNP-self. If a defect exists in H-2 bstimulating cells, it is not reversed by using the most potent stimulating cell population known (24) , because the use of TNBS-modified, splenic-adherent stimulating cells resulted in the same genetic differences observed when unfractionated spleen cells were used as stimulators.
/r-like genetic effects have been demonstrated for H-2-restricted (1-3) and crossreactive (21, 29) cytotoxic responses to TNP-self, as well as for restricted cytotoxic responses to virus-infected cells (7) (8) (9) (10) (11) (12) and cells expressing the HY antigen (13) . Responses of (B10 × B10.BR)F1 spleen cells stimulated by B10.BR-, B10-, or F1-stimulating cells modified with low concentrations of TNBS were investigated by The TNP-dose-dependent differences observed in the present study could be TNPspecific, i.e., they could be specific for the modifying hapten or infectious agent, or these results could imply the existence of a general H-2-1inked response pattern to limiting antigen doses which would be H-2 self specific and not determined by the particular antigen recognized in association with self. It should be noted in this context that H-2-restricted cytotoxic responses to limiting doses of virus appear in preliminary experiments to exhibit a similar strain-dependent pattern (W. E. Biddison and G. M. Shearer, unpublished observations). This also agrees in general with the H-2-restricted CTL (33) and skin graft (34) results to the HY antigen in which responses involving//-2 k appear to be stronger than those involving//-2 b or//-2 a. Our observation that the genetic differences between B10 and B10.BR mice could be detected by lowering the stimulating cell number (modified with an excess of 10 mM TNBS) suggests that a component other than TNP is limiting. That component could be H-2 b and H-2 a self-recognition determinants. It is possible that the self-recognition determinant coded for by H-2K* genes provides an unusually efficient structure for CTL, and thereby represents the exception rather than the examples shown for//-2 a and H-2 b. Preferential recognition of K ~ self determinants over D b and D a have been reported in viral (9-11) and TNP (1-3) CML studies, and the responses demonstrated to low doses of TNP-self in H-2* and/-/-2 ~ mice may reflect immunodominance of H-2K* (9).
The present study demonstrates that TNP-specific H-2-restricted eytotoxic responses are controlled by H-2-1inked genes, the effects of which can be clearly detected only when the responding cells are exposed to relatively low concentrations of TNP. Although TNP is not an infectious or pathogenic agent, the ease with which different amounts of this hapten can be conjugated to cell surfaces makes the system potentially useful as a model for investigating H-2-restricted viral systems. The possibility exists that similar MHC-linked genetic effects which are not detected at relatively high doses of immunogen may be demonstrable at lower immunogen doses for other MHCrestricted CTL systems such as viruses. Antigen dose-dependent genetic regulation by the MHC could be critical for initiating T-cell immune reactivity after chronic infections.
Summary
Spleen cells from B10.BR and C57BL/10 (B10) mice were compared for their ability to generate primary in vitro cytotoxic responses to syngeneic cells modified with different concentrations (from 10 to 0.031 mM) of trinitrobenzene sulfonate (TNBS) (TNP-self). Although both strains generated effector cells to TNP-self in the range of 10-0.25 mM TNBS modification, effector activity of B10 cells was weaker than that of B10.BR cells. BI0 spleen cells did not respond to syngeneie stimulating cells modified at 0.1 mM or lower, whereas B10.BR cells generated effector activity even when stimulated by TNP-self modified with as low as 0.031 mM TNBS. Fluorescence analysis of the modified cells using the FACS II indicated that equivalent quantities of TNP were conjugated to the surfaces of B 10.BR and B 10 spleen cells for any given concentration of TNBS modification. Similar strain-dependent differences were observed when the TNP was diluted out in the cultures by reducing the number of stimulating cells modified with 10 mM TNBS. These response patterns were verified by stimulating cultures of BI0.BR and B10 spleen cells either with TNP conjugated to bovine serum albumin or bovine gamma globulin (B10.BR but not B10 cells responded to TNP-conjugated proteins) or with TNBS-modified glassadherent spleen cells. The strain-dependent differences could also be detected at the effector phase, because optimally stimulated B 10.BR, but not B 10 effector cells, could lyse 0.1 mM TNBS-modified syngeneic target cells. The genetic parameters associated with the response and nonresponse patterns of B10.BR and B10 mice were further investigated by comparing the cytotoxic responses to low doses of TNP-self of spleen cells from the following strains: (a) C3H/HeJ (H-2 k) and C3H.SW (H-2b); (b) BALB.K (H-2 ~) and BALB.B (H-2b); and (c) B10.A (H-2 a) and BI0.D2 (H-2a). The H-2 k and H-2 ~, but not the H-2 ~ and H-2 a, strains generated cytotoxic responses to TNP-self when the syngeneic stimulators were modified with 0.1 mM TNBS. Further studies using (B10 × B10.BR)F1 responding cells and parental or Fl-modified stimulating cells, indicated that the F1 cells generated cytotoxic activity to low doses of TNP in association with H-2 ~ but not in association with H-2 b self products. The results of this study indicate that H-2-1inked genetic factors, expressed in the target as well as in the responding and/or stimulating cell populations, control the ability of inbred mouse strains to generate cytotoxic effector cells to low doses of TNP-self. Such dosedependent genetic effects may be important in the regulation of immune responses activated in vivo by chronic exposure to infectious agents.
